Cinatl, Jindrich, Michaelis, Martin, Hoever, Gerold, Preiser, Wolfgang, Doerr, Hans Wilhelm (2005) Development of antiviral therapy for severe acute respiratory syndrome. Antiviral Research, 66 (2-3). pp. 81-97. ISSN 0166-3542. (doi:10.1016/j.antiviral.2005.03.002) (The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided) (KAR id:34109)
| The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided. | |
| Official URL: http://dx.doi.org/10.1016/j.antiviral.2005.03.002 |
|
Abstract
A new disease, the severe acute respiratory distress syndrome (SARS), caused by the SARS coronavirus (SARS-CoV), emerged at the beginning of 2003 and rapidly spread throughout the world. Although the disease had disappeared in June 2003 its re-emergence cannot be excluded. The development of vaccines against SARS-CoV may take years. Therefore, the availability of effective antiviral drugs against SARS-CoV may be crucial for the control of future SARS outbreaks. In this review, experimental and clinical data about potential anti-SARS drugs is summarised and discussed. Animal model studies will be needed to help to determine which interventions warrant controlled clinical testing.
| Item Type: | Article |
|---|---|
| DOI/Identification number: | 10.1016/j.antiviral.2005.03.002 |
| Subjects: | R Medicine > RM Therapeutics. Pharmacology |
| Institutional Unit: | Schools > School of Natural Sciences > Biosciences |
| Former Institutional Unit: |
Divisions > Division of Natural Sciences > Biosciences
|
| Depositing User: | Martin Michaelis |
| Date Deposited: | 05 Jun 2013 20:37 UTC |
| Last Modified: | 20 May 2025 09:17 UTC |
| Resource URI: | https://kar.kent.ac.uk/id/eprint/34109 (The current URI for this page, for reference purposes) |
- Export to:
- RefWorks
- EPrints3 XML
- BibTeX
- CSV
- Depositors only (login required):

https://orcid.org/0000-0002-5710-5888
Altmetric
Altmetric